4 research outputs found
Coupling of HPLC with Electrospray Ionization Mass Spectrometry for Studying the Aging of Ultrasmall Multifunctional Gadolinium-Based Silica Nanoparticles
Sub-5
nm multimodal nanoparticles have great potential for theranostic
applications due to their easy renal elimination combined with complementary
imaging properties and therapeutic facilities. Their potential clinical
use requires the full characterization of not only the nanoparticle
but also all its possible degradation products. We have recently proposed
new ultrasmall gadolinium-based nanoparticles for multimodal imaging
and radiosensitization. The aim of this article is to describe an
analytical tool to characterize degradation products in a highly diluted
medium. We demonstrate that HPLC coupled to electrospray ionization
mass spectrometry (ESI-MS) can be used in order to determine precisely
the composition of nanoparticles and their degradation fragments during
aging
Ultrasmall Silica-Based Bismuth Gadolinium Nanoparticles for Dual Magnetic Resonance–Computed Tomography Image Guided Radiation Therapy
Selective
killing of cancer cells while minimizing damage to healthy tissues
is the goal of clinical radiation therapy. This therapeutic ratio
can be improved by image-guided radiation delivery and selective radiosensitization
of cancer cells. Here, we have designed and tested a novel trimodal
theranostic nanoparticle made of bismuth and gadolinium for on-site
radiosensitization and image contrast enhancement to improve the efficacy
and accuracy of radiation therapy. We demonstrate in vivo magnetic
resonance (MR), computed tomography (CT) contrast enhancement, and
tumor suppression with prolonged survival in a non-small cell lung
carcinoma model during clinical radiation therapy. Histological studies
show minimal off-target toxicities due to the nanoparticles or radiation.
By mimicking existing clinical workflows, we show that the bismuth–gadolinium
nanoparticles are highly compatible with current CT-guided radiation
therapy and emerging MR-guided approaches. This study reports the
first in vivo proof-of-principle for image-guided radiation therapy
with a new class of theranostic nanoparticles
High-Resolution Cellular MRI: Gadolinium and Iron Oxide Nanoparticles for in-Depth Dual-Cell Imaging of Engineered Tissue Constructs
Recent advances in cell therapy and tissue engineering opened new windows for regenerative medicine, but still necessitate innovative noninvasive imaging technologies. We demonstrate that high-resolution magnetic resonance imaging (MRI) allows combining cellular-scale resolution with the ability to detect two cell types simultaneously at any tissue depth. Two contrast agents, based on iron oxide and gadolinium oxide rigid nanoplatforms, were used to “tattoo” endothelial cells and stem cells, respectively, with no impact on cell functions, including their capacity for differentiation. The labeled cells’ contrast properties were optimized for simultaneous MRI detection: endothelial cells and stem cells seeded together in a polysaccharide-based scaffold material for tissue engineering appeared respectively in black and white and could be tracked, at the cellular level, both <i>in vitro</i> and <i>in vivo</i>. In addition, endothelial cells labeled with iron oxide nanoparticles could be remotely manipulated by applying a magnetic field, allowing the creation of vessel substitutes with in-depth detection of individual cellular components
Functionalization of Small Rigid Platforms with Cyclic RGD Peptides for Targeting Tumors Overexpressing α<sub>v</sub>β<sub>3</sub>‑Integrins
Gadolinium based Small Rigid Plaforms
(SRPs) have previously demonstrated
their efficiency for multimodal imaging and radiosensitization. Since
the RGD sequence is well-known to be highly selective for α<sub>v</sub>β<sub>3</sub> integrins, a cyclic pentapeptide containing
the RGD motif (cRGDfK) has been grafted onto the SRP surface. An appropriate
protocol led to the grafting of two targeting ligands per nano-object.
The resulting nanoparticles have demonstrated a strong association
with α<sub>v</sub>β<sub>3</sub> integrins in comparison
with cRADfK grafted SRPs as negative control. Flow cytometry and fluorescence
microscopy have also been used to highlight the ability of the nanoparticles
to target efficiently HEK293(β3) and U87MG cells. Finally the
grafted radiosensitizing nanoparticles were intravenously injected
into <i>Nude</i> mice bearing subcutaneous U87MG tumors
and the signal observed by optical imaging was twice as high for SRP-cRGDfK
compared to their negative analogue